Why Some Cancers May Respond Poorly to Key Drugs Discovered
September 22, 2020 4:00 pmPatients with BRCA1/2 mutations are at higher risk for breast, ovarian and prostate cancers that can be aggressive when they develop—and, in many cases, resistant to lifesaving drugs. Now scientists at The University of Texas at Austin and Ajou University … Read more